AK-2292 is primarily used in research settings as a potent and selective inhibitor targeting specific kinase pathways involved in cellular signaling. It has shown promise in studies related to inflammatory diseases and cancer due to its ability to modulate key enzymes that regulate cell proliferation and immune responses. Its high selectivity makes it a valuable tool for probing kinase function in biochemical assays and preclinical models. Researchers also utilize AK-2292 to investigate signal transduction mechanisms and to support the development of new therapeutic agents targeting kinase-driven pathologies.